Literature DB >> 24445944

[The skin's own antibiotics. Important features of antimicrobial peptides for clinical practice].

J Cordes1, M Wittersheim, J Harder, R Gläser.   

Abstract

Despite permanent confrontation with a potentially harmful environment, its own microbiota and the fact that minor injuries occur frequently in everyday life, skin infections are a rare event. A chemical barrier of antimicrobial peptides (AMP), some of them constitutively expressed, others inducible by various stimuli, contributes to the integument's resistance. AMP are evolutionarily old components of the innate immunity which became the focus of interest due to their broad spectrum of activity against microorganisms and the rare occurrence of antimicrobial resistance. These attributes make them promising alternative candidates for future antibiotics. Furthermore various dermatological diseases are associated with an altered expression of these molecules, which might then play a pathogenetic role. In addition to their antimicrobial activity, some AMP have immunomodulatory effects and can promote wound healing, properties which currently are under intensive research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445944     DOI: 10.1007/s00105-013-2638-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  41 in total

1.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

Authors:  B Schittek; R Hipfel; B Sauer; J Bauer; H Kalbacher; S Stevanovic; M Schirle; K Schroeder; N Blin; F Meier; G Rassner; C Garbe
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

2.  RNase 7 protects healthy skin from Staphylococcus aureus colonization.

Authors:  Maren Simanski; Stefanie Dressel; Regine Gläser; Jürgen Harder
Journal:  J Invest Dermatol       Date:  2010-07-29       Impact factor: 8.551

3.  RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin.

Authors:  Jurgen Harder; Jens-Michael Schroder
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

Review 4.  Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation.

Authors:  Miriam Wilmes; Bruno P A Cammue; Hans-Georg Sahl; Karin Thevissen
Journal:  Nat Prod Rep       Date:  2011-05-27       Impact factor: 13.423

5.  A peptide antibiotic from human skin.

Authors:  J Harder; J Bartels; E Christophers; J M Schröder
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

6.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

7.  Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata.

Authors:  U Meyer-Hoffert; T Schwarz; J-M Schröder; R Gläser
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-03-18       Impact factor: 6.166

8.  The skin surface as antimicrobial barrier: present concepts and future outlooks.

Authors:  Jürgen Harder; Jens-Michael Schröder; Regine Gläser
Journal:  Exp Dermatol       Date:  2012-10-23       Impact factor: 3.960

9.  Expression of human beta-defensins in patients with mycosis fungoides.

Authors:  T Gambichler; M Skrygan; C Appelhans; N S Tomi; A Reinacher-Schick; P Altmeyer; A Kreuter
Journal:  Arch Dermatol Res       Date:  2007-04-06       Impact factor: 3.017

Review 10.  [Vitamin D and innate immunity of the skin].

Authors:  M Reinholz; J Schauber
Journal:  Dtsch Med Wochenschr       Date:  2012-11-06       Impact factor: 0.628

View more
  2 in total

Review 1.  [Neurodermatitis : Atopy of the skin].

Authors:  R Fölster-Holst
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 2.  Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.

Authors:  Anja Pfalzgraff; Klaus Brandenburg; Günther Weindl
Journal:  Front Pharmacol       Date:  2018-03-28       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.